Introduction
============

Although zebrafish (*Danio rerio*) have been used in science since the 1970s ([@B34]), only in the last decade have they become a relevant model to study human diseases such as cancers, cardiovascular and muscular malformations, and depressive disorders ([@B53]; [@B33]; [@B89]; [@B79]; [@B55]). Moreover, zebrafish have been used for studying animal and human infectious disease ([@B71]; [@B72]) because its immune system is similar to that of mammals ([@B27]; [@B58]; [@B84]; [@B100]). The immune system of adult zebrafish includes almost all lymphoid organs and immune cell types ([@B98]; [@B50]; [@B84]). At early developmental stages, up to approximately 2 weeks post-fertilization, only innate immunity is active, mainly comprising macrophages and neutrophils ([@B38]; [@B54]; [@B47]; [@B48]). Because of its low cost and easy large-scale breeding, zebrafish is a convenient animal model compared with rodents for identifying the roles of new genes involved in disease processes and for high-throughput applications such as drug screening ([@B76]; [@B39]; [@B59]; [@B74]).

Using zebrafish, infectious processes can be described in detail using *in vivo* imaging techniques because of their small size and transparency during the first week after fertilization. These techniques primarily include differential interferential contrast (DIC) and fluorescence microscopy ([@B75]; [@B35]; [@B63]; [@B10]). The availability of fluorescent pathogens and transgenic reporter zebrafish lines expressing fluorescent immune cells, immune marker genes or cytokines/chemokines allows the host--pathogen interactions to be described in detail ([@B8]; [@B94]; [@B64]; [@B97]). Zebrafish larvae have been used to analyze the innate immune response after bacterial infections such as *Mycobacterium marinum* ([@B49]; [@B104]; [@B2]; [@B62]), *Streptococcus* sp. ([@B69]), *Salmonella typhimurium* ([@B99]), *Staphylococcus aureus* ([@B8]; [@B52]) and *Burkholderia cenocepacia* ([@B102]; [@B66]).

Important new insights into human infectious diseases mechanisms have been uncovered by these infection models. *Mycobacterium marinum* is closely related to the global human pathogen *Mycobacterium tuberculosis* ([@B62]). In zebrafish, *M. marinum* induces the formation of granulomas, which are the typical histopathological hallmark of human tuberculosis, so the *M. marinum* infection model is used to study human tuberculosis. This model highlights the fact that the stabilization of the transcription factors hypoxia-inducible factor α (HIF-α) favors the host response against *M. marinum*; the CXCR3/CXCL11 signaling axis is involved in macrophage recruitment and dissemination of mycobacterial infection, and Dram-1-mediated autophagy is an important host defense to counteract mycobacterium infection ([@B28]; [@B96]; [@B62]). These findings represent a potential target for therapeutic intervention against tuberculosis ([@B62]; [@B68]). The infection of zebrafish larvae with *Burkholderia cenocepacia*, which is an opportunistic pathogen of cystic fibrosis or immunocompromised individuals, revealed that this pathogen survives within macrophages, where it can replicate, and thereafter disseminates to produce fatal bacteraemia and that a functional CepIR quorum-sensing system is required for intracellular replication and dissemination ([@B102]). *Salmonella typhimurium* infections highlight the importance of the mitochondria-associated enzyme immunoresponsive gene 1 (IRG1) in the intracellular degradation of phagocytosed bacteria. This enzyme, which is expressed by macrophages, directs the mitochondrial catabolism of fatty acids for the production of mitochondrial ROS, contributing to the clearance of intracellular bacteria ([@B36]). This result underlines the importance of the connection between metabolism and immunity for the study of infectious diseases and highlighted IRG1 as a new therapeutic target for intracellular bacterial infections ([@B36]). Other bacterial infection models in zebrafish, such as *Pseudomonas aeruginosa*, *Edwardsiella tarda*, and *Listeria monocytogenes*, have been used to determine the pathogenicity-related factors and resistance strategies of the host ([@B82]; [@B12]; [@B51]). Nevertheless, the use of zebrafish larvae for the study of the pathogenesis of *A. hydrophila* has never been explored.

The Gram-negative bacterium *Aeromonas hydrophila* is a motile, rod-shape, facultative anaerobic bacterium that is an opportunistic pathogen of fish and terrestrial animals ([@B42]; [@B40]). In fish, it causes motile aeromonas septicaemia (MAS), a disease that leads to a high mortality ([@B37]). In humans, *A. hydrophila* can cause gastroenteritis, septicaemia, tissue infections and other, less frequent complications, such as peritonitis, endocarditis, pancreatic infections, and urinary tract infections ([@B42]). Clinical conditions such as cancer, hepatic diseases, diabetes and trauma increase the risk to develop a fatal *A. hydrophila* infection ([@B77]). The pathogenicity of *A. hydrophila* is multifactorial, depending on several virulence factors: enterotoxins (e.g., Act, Ast and Alt), haemolysins (α and β), Shiga toxins, extracellular enzymes such as proteases and nucleases, type 3 and type 6 secretion systems (T3SSs, T6SSs) and motility factors such as lateral and polar flagella ([@B4]; [@B95]). Although *A. hydrophila* is naturally present in the gut microbiota of zebrafish ([@B18]), it is able to generate an acute infection in adults ([@B86]), but no information is available about the pathogenic process and host immune response in embryos.

Numerous studies have been conducted to identify the mechanisms of infection, the main virulence factors and the host immune response triggered by *A. hydrophila* in murine and adult fish models ([@B110], [@B111]; [@B90]; [@B15], [@B16]; [@B103]; [@B86], [@B85]; [@B61]; [@B17]; [@B57]). Therapeutic strategies such as immunomodulatory molecules and vaccines have been developed in some fish species (carp, zebrafish, and rainbow trout) to protect the animals against *A. hydrophila* infection ([@B85]; [@B80]; [@B5]; [@B13]; [@B19]; [@B56]). Mice and adult zebrafish have been experimentally infected by intramuscular or intraperitoneal injections ([@B90]; [@B111]; [@B86], [@B85]; [@B20]), and orally by gavage or exposing the zebrafish to the bacteria in the water ([@B107]; [@B1]; [@B57]). The infectious process has been evaluated by measuring the mortality rates, bacterial burden, respiratory burst, immune gene expression, quantification of leukocytes by flow cytometry, and tissue damage by histological assays ([@B31]; [@B91]; [@B93]; [@B52]). The great limitation of those methods is that they require the sacrifice of the animals and the extraction of tissues/organs to perform all of the analyses, thereby preventing the study of the infectious processes in the whole living animal.

To overcome this limitation, we chose zebrafish larvae to study *Aeromonas hydrophila* infections. The exceptional transparency of zebrafish larvae allowed us to follow the infection process without killing the animal through non-invasive *in vivo* imaging of individual cells and host--pathogen interactions at high resolution. Pathogens, immune cells and immune factors can be visualized in three-dimensional tissue architecture evidencing tissue/organs specific immune responses. In this way, it is possible to image the phagocytic activity of host immune cells and the interactions between host cells and microbe ([@B64]). These useful features of the zebrafish model coupled with the possibility to simulate the natural mode of *A. hydrophila* infections, i.e., by bath infections, would allow the evaluation of the exact contribution of each bacterial virulence factor to *A. hydrophila* pathogenesis. By using *A. hydrophila* mutants for different virulence factors, it could be possible uncover the specific role of each in the *A. hydrophila* diseases. In addition, the high number of animals available for experiments permits the performance of high-throughput screenings of virulence ([@B106]; [@B92]).

Thus, the starting hypothesis of the present study is that the zebrafish larvae are a suitable animal model for the study of the pathogenesis of *A. hydrophila* and the interaction mechanisms between the bacterium and the innate immune system. We exposed zebrafish to infection by three different routes. First was an early-embryo infection model at 3 days post-fertilization (dpf) through the microinjection of *A. hydrophila* into the duct of Cuvier, caudal vein, notochord, or muscle. The other two were bath infection models using 4 dpf healthy and injured larvae. The bath infection simulated the natural conditions by which *A. hydrophila* produces infectious diseases in animals. The duct of Cuvier is a wide blood circulation valley on the yolk sac where the anterior and posterior cardinal vessels join ([@B44]). Because the duct of Cuvier connects the heart to the trunk vasculature, it has been used to introduce pathogens such as *Staphylococcus aureus*, *Pseudomonas aeruginosa*, *Mycobacterium marinum*, and *Salmonella typhimurium* into the blood circulation by microinjection ([@B21]; [@B23]; [@B8]; [@B52]). The caudal vein is another frequent route to inject pathogens into the bloodstream to produce systemic infections ([@B23]). It has been used for pathogens such as *Mycobacterium marinum* ([@B62]), *Salmonella typhimurium* ([@B99]), *Burkholderia cenocepacia* ([@B66]), *Staphylococcus aureus* ([@B52]), *Pseudomonas aeruginosa* ([@B12]), *Streptococcus pneumoniae* ([@B87]), and *Listeria monocytogenes* ([@B51]). Notochord and muscle are alternative injection routes that are used to produce local infections ([@B23]; [@B8]). Notochordal infections have been performed to administer pathogens such as *Escherichia coli* ([@B70]) and *Mycobacterium marinum* ([@B3]), and muscle injections have been performed to study microbes such as *Salmonella typhimurium* ([@B112]), *Escherichia coli* ([@B70]), and *Francisella* spp. ([@B14]).

It is critical to establish the correct infection parameters because the site, timing, and dose of the microinjection of bacteria into the embryo are important factors that determine the bacterial infection of the host ([@B8]). We observed the cellular processes after infection in each anatomical site by confocal fluorescence imaging and determined the implication of inflammatory immune genes by measuring gene expression by qPCR.

Materials and Methods {#s1}
=====================

Ethics Statement
----------------

Fish care and experiments were performed according to EU guidelines^[1](#fn01){ref-type="fn"}^. All of the protocols were revised and approved by the CSIC Spanish National Committee on Bioethics (151/2014).

Fish
----

The zebrafish (*Danio rerio*) lines used in the experiments were the wild type AB variety and the homozygous transgenic lines *Tg(mpx:GFP+/+)* and *Tg(il-1b:GFP-F+/+)* ([@B83]; [@B70]). Mixed male and female populations of zebrafish were kept in 9-liter tanks at 28°C. Embryos were obtained by natural spawning and reared in E3 egg water for 3 days until hatching ([@B106]). Embryos at 3 and 4 dpf were used in the experiments.

Bacteria
--------

The *Aeromonas hydrophila* AH-1 strain ([@B110]) and the fluorescent *A. hydrophila* Ds-Red (kindly provided by Dr. Van der Sar, The Netherlands) were used. For experimental infections, the bacteria were grown on tryptic soy agar (TSA) plates overnight at 28°C and were resuspended in phosphate-buffered saline (PBS) to obtain a stock solution containing 10^10^ colony-forming units (CFUs)/mL (OD~620nm~ = 1.3). Dilutions to the desired concentration were prepared for the different experimental infections.

Infection Models
----------------

Two different routes of bacterial inoculation were assayed. A microinjection model was used to produce local or systemic infections depending on the anatomical site of injection. Two bath infection models were used, in which the animals were exposed to the bacteria in the water. The two bath infection models were immersion only and immersion after injury, in which the animals were injured in the tail fin tip to generate an alternative portal of entry to the bacteria.

### Microinjection Model

AB zebrafish larvae at 3 dpf were anesthetized in E3 eggs water containing 160 μg/ml MS-222 (Sigma--Aldrich), placed on an agarose plate and individually microinjected using pulled glass microcapillary pipettes (WPI, USA). Larvae were microinjected with 1 nL of an *A. hydrophila* solution (3200 CFU/nL) into the duct of Cuvier, caudal vein, notochord, or muscle, following the recommendations described by [@B8]. The first control group was injected with the same volume of PBS in the duct of Cuvier. The second control group was injected with the same volume of dead *A. hydrophila* to show that the death of larvae was not simply caused by a general process in response to the infection. Microinjection was performed using the micromanipulator Narishige IM-30 and the stereo microscope SMZ800 (Nikon). In all experiments the control group was injected with the same volume of PBS. The exact bacterial concentration injected into the animals was determined by plating dilutions of the injected solution onto LB agar and counting the obtained CFUs after overnight incubation at 28°C. Infected and control larvae were maintained at 28°C in six wells plate (Falcon) containing 6 ml of E3 egg water. Animals were regularly observed, and cumulative mortalities were registered until 5 days post-infection (dpi). Three independent experimental infections were conducted. A total of 40 animals (four biological replicates of 10 larvae each) were infected through each anatomical site.

The duct of Cuvier was selected for additional experimental infections. Larvae were microinjected with 1 nL of an *A. hydrophila* dilution (3175 CFU/nL, 1150 CFU/nL, or 375 CFU/nL). Three independent experimental infections were conducted. A total of 40 animals (four biological replicates of 10 larvae each) were infected in each trial.

### Bath Infection Model

AB zebrafish larvae (healthy) at 4 dpf were used for bath immersion infections. Two models were used: immersion only and immersion after injury, in which the animals were injured in the tail fin tip before the infection. Experimental infections of healthy and injured larvae were performed in parallel using the same bacterial suspension at the same concentration. To produce a wound in larvae, animals were anesthetized and placed on a Petri dish filled with 1% low-melting-point agarose (Sigma--Aldrich). A small transection of the tail fin was done using a sapphire blade (WPI) under the stereomicroscope SMZ800 (Nikon).

Groups of 10 healthy and injured larvae were distributed into 6-well plates (Falcon) containing 6 ml of sterile E3 eggs' water. For the infection, *A. hydrophila* stock solution was added to each well to reach a final concentration of 10^8^ CFU/mL, and the plates were incubated at 28°C. Injured larvae were immediately immersed in the bacterial solution after the transection of the tail. The inoculated bacterium was kept in the water throughout the experiment. The control groups (injured and healthy larvae) were treated with PBS. Cumulative mortalities were registered until 6 dpi. The experimental infections were performed 5 times using four biological replicates of 10 larvae each.

Bacterial Load in Fish during Infection
---------------------------------------

The bacterial load in fish was measured after microinjection (0 and 24 hpi) or bath infection (1, 6, and 24 hpi). Four groups of 10 microinjected larvae and the same number of bath-infected larvae were anesthetized with a lethal dose of MS-222 (Sigma--Aldrich), transferred into a tube containing 200 μl of 1% Triton-X100 (BIO-RAD) and mechanically homogenized. Serial dilutions of the homogenates were prepared in PBS and plated in selective TSA plates. CFUs were counted after overnight incubation at 28°C in two independent experiments.

*In vivo* Characterization of the Cellular Immune Response by Fluorescence Microscopy
-------------------------------------------------------------------------------------

The homozygous transgenic zebrafish line *Tg(mpx:GFP+/+)*, expressing fluorescent neutrophils, was used to visualize the response of neutrophils to the infection ([@B83]). The homozygous transgenic zebrafish line *Tg(Il-1b:GFP-F+/+)*, expressing GFP under the control of the Il-1β promoter was used to visualize the expression of Il-1β gene ([@B70]). In all experiments, *N*-phenylthiourea 0.2 mM (PTU; Sigma) was used to prevent pigment formation.

Larvae at 3 dpf were injected with 1 nL of an *A. hydrophila* suspension in the different anatomical sites as described above. The bacterial suspension injected in the *Tg(mpx:GFP+/+)* and *Tg(Il-1b:GFP-F+/+)* contained 5600 CFU/nL and 1400 CFU/nL, respectively. The first control group was injected with the same volume of PBS in the duct of Cuvier. The second control group was injected with the same volume of dead *A. hydrophila.* At 6 hpi, animals were fixed in 4% paraformaldehyde, washed in PBS-Tween 0.1% (Sigma--Aldrich) and imaged in a TSC SPE confocal microscope (Leica) using a 10X HCX APO (L 0.30 W U-V-I) water objective (Leica). Additional infections of *Tg(mpx:GFP+/+)* larvae by injection in the duct of Cuvier (1 nL of a bacterial suspension containing 200 CFU/nL) were conducted and imaged using a TSC SPE confocal microscope (Leica). The total neutrophils were counted at different times post-infection (2, 4, 6, and 24 h) using the ImageJ software ([@B29]). Neutrophils were counted in two independent experiments using 10 larvae at each time point.

The involvement of neutrophils was also evaluated in 4 dpf healthy and injured *Tg(mpx:GFP+/+)* larvae at 1 h after bath infection. Animals were infected with *A. hydrophila* DsRed (at a final concentration of 10^8^ CFU/mL), and the neutrophils in the injured area were counted as above using the TSC SPE confocal microscope (Leica) and ImageJ. Neutrophils were counted in three independent experiments using 10--15 larvae. Z-stacks images were used for 3D reconstructions using the Image Surfer software ([@B32]).

qPCR
----

The expression of the proinflammatory genes TNFα and IL-1β was evaluated in AB larvae after bath exposure or microinjection in the duct of Cuvier. Healthy and injured larvae (*n* = 30 fish/group) were bath-infected with 10^8^ CFU/mL *Aeromonas* and sampled at 1, 3, and 5 hpi. For microinjection in the duct of Cuvier, 30 larvae were injected with 1 nL of *A. hydrophila* (120 CFU/nL) and sampled at 6 hpi. In both experimental infections, three biological replicates, 10 larvae per replicate, were sampled in each sampling point and suspended in 200 μl lysis buffer (Promega). Total RNA was isolated using the Maxwell^®^ 16 LEV simply RNA Tissue kit (Promega) according to the manufacturer's instructions. First-strand cDNAs were synthesized using SuperScript II (Life Technologies) from 500 μg of total RNA per sample. Specific qPCR primers were designed using the Primer3 software ([@B88]) (**Table [1](#T1){ref-type="table"}**). The efficiency of the primer pairs was analyzed with seven serial fivefold dilutions of cDNA and calculated from the slope of the regression line of the cycle thresholds (Cts) versus the relative concentration of cDNA ([@B78]).

###### 

Sequence of primers used for qPCR experiments.

  Gene    Primer    Sequence (5′--3′)        Amplicon (bp)   Efficiency
  ------- --------- ------------------------ --------------- ------------
  EF1α    Forward   GCATACATCAAGAAGATCGGC    121             -3.45
          Reverse   TCTTCCATCCCTTGAACCAG                     
  TNFα    Forward   ACCAGGCCTTTTCTTCAGGT     148             -3.38
          Reverse   GCATGGCTCATAAGCACTTGTT                   
  IL-1β   Forward   TTCCCCAAGTGCTGCTTATT     149             -3.33
          Reverse   AAGTTAAAACCGCTGTGGTCA                    

qPCR was carried out in a 7300 Real Time PCR System (Applied Biosystems) using standard cycling conditions. One microliter of cDNA was mixed with 0.5 μl of each primer (final concentration 10 mM), 12.5 μl of SYBR green PCR master mix (Applied Biosystems) and 10.5 μl of water. The elongation factor 1-alpha gene (EF1α) was used as the normalization gene because it was constitutively expressed and not affected by the bacterial infection. The relative expression levels of TNFα and IL-1β were normalized using the expression levels obtained for the EF1α gene. Fold units were calculated by dividing the normalized expression values obtained in infected samples by the normalized expression values obtained in the control at each sampling point ([@B78]). The results of three independent experimental infections were expressed as the mean ± standard error.

Statistical Analysis
--------------------

All data were analyzed using Student's *t*-test (two-tailed, unpaired). The results are presented as the means ± SEM. *P* \< 0.05 (\*); *P* \< 0.01 (\*\*); and *P* \< 0.005 (\*\*\*) were considered significant. Multiple-comparison ANOVA and the Tukey HSD test were conducted to evaluate the variations in the number of neutrophils and the evolution of the gene expression.

Results
=======

Development of the Microinjection Model
---------------------------------------

The microinjection of *A. hydrophila* in 3 dpf larvae generated two different types of infections according to the selected anatomical site. Injection in the duct of Cuvier or in the caudal vein generated a systemic infection (**Figure [1](#F1){ref-type="fig"}**, panels A1 and A2), and injection in the muscle or notochord induced a local infection (**Figure [1](#F1){ref-type="fig"}**, panels A3 and A4).

![**(A)** Anatomical distribution of the selected sites for microinjection. The duct of Cuvier (A1) and the caudal vein (A2) were selected to establish systemic infections. Injection in the muscle (A3) or notochord (A4) induced a local infection. Cv, caudal vein; Da, dorsal aorta; M, muscle; N, notochord. **(B)** Evolution of cumulative mortality in larvae infected with 1 nL of an *A. hydrophila* solution (3200 CFU/nL). The graph shows a representative result of the three independent experiments conducted. Forty larvae were injected in each anatomical site. No significant differences were observed between the mortality registered using the different injection sites throughout the experiment.](fmicb-07-01219-g001){#F1}

The experimental infection of larvae with *A. hydrophila* (3200 CFU/nL) induced elevated mortality regardless of the site selected for the injection. In both local and systemic infections, mortality started as soon as 12 hpi and reached a 65--73% cumulative mortality at 96 hpi. In all cases, no significant differences in cumulative mortality were registered between systemic and local infections. No mortalities were registered in fish injected with the same volume of PBS or dead *A. hydrophila* (**Figure [1B](#F1){ref-type="fig"}**).

The experimental infection of the *Tg(mpx:GFP+/+)* larvae allowed us to characterize the *in vivo* response of neutrophils to the bacteria by fluorescence microscopy (**Figure [2A](#F2){ref-type="fig"}**). A strong migration of neutrophils to the injection area was clearly observed after 6 hpi in the muscle and the notochord (**Figure [2A](#F2){ref-type="fig"}**). At this time, the injection in the duct of Cuvier induced less neutrophil migration compared to that observed in the muscle or notochord. The injection in the caudal vein did not induce local migration to the site of injection (**Figure [2A](#F2){ref-type="fig"}**). The injection in the duct of Cuvier or caudal vein induced a general increase in the number of neutrophils compared to the PBS-injected control group (**Figure [2A](#F2){ref-type="fig"}**).

![**(A)** *In vivo* imaging of neutrophil migration after infection of *Tg(mpx:GFP+/+)* larvae with *A. hydrophila*. Larvae were injected with 1 nL of *A. hydrophila* (5600 CFU/nL) and imaged at 6 hpi. Images show differential migration of neutrophils depending on the anatomical site of injection. **(B)** Anatomical distribution of IL-1β gene expression in larvae microinjected at different anatomical sites. *Tg(il-1b:GFP+/+)* larvae were injected with 1 nL of *A. hydrophila* (1400 CFU/nL) and imaged at 6 hpi. Overlay of IL1-β expression (green), with the transmission channel used as an anatomical guide. The white arrows indicate the positions of the injection sites.](fmicb-07-01219-g002){#F2}

The *Tg(il-1b:GFP-F+/+)* larvae were also used to visualize the anatomical distribution of Il-1β expression after the infection in the different sites. Different tissue localization of Il-1β expression was observed depending on the injection route (**Figure [2B](#F2){ref-type="fig"}**). Larvae microinjected in the muscle or in the notochord showed strong IL-1β expression around the injection site and also in the gills and the tail fin. Larvae injected in the duct of Cuvier or caudal vein presented the strongest IL-1β expression along the intestine. Larvae injected in the caudal vein showed elevated IL-1β expression in the tail fin. The expression observed in the gills was lower than that observed in larvae injected in the muscle or notochord (**Figure [2B](#F2){ref-type="fig"}**). In all cases the distribution of the IL-1β expression after infection was highly representative because 80% of the larvae injected in the same site presented similar GFP distribution.

Larvae injected with the dead bacteria in the duct of Cuvier showed a neutrophil distribution and IL-1B expression similar to that observed in PBS injected larvae (data not shown).

### Infection Model by Injection in the Duct of Cuvier

The injection in the duct of Cuvier was selected for additional experiments because this route was the easiest to generate a quick systemic infection and because it induced a local inflammatory reaction. With these experiments, we developed a more detailed description of mortality kinetics and the induction of immune response.

The injection of 3175 CFU/nL induced mortality rates similar to those obtained in previous experiments, reaching 100% cumulative mortality at the end of the experiment (**Figure [3A](#F3){ref-type="fig"}**). The dilution of the bacteria induced a significant decrease in mortality (less than 20% at the end of the experiment; **Figure [3A](#F3){ref-type="fig"}**). The evolution of the bacterial burden was analyzed to evaluate whether the microinjection in the duct of Cuvier induced a stable bacterial infection. The bacterial burden of viable bacteria did not change significantly from 0 to 24 hpi (575 and 340 CFU at 0 and 24 hpi, respectively; **Figure [3B](#F3){ref-type="fig"}**).

![**Infection model by microinjection in the duct of Cuvier. (A)** Cumulative mortality in larvae injected with various doses of bacteria (3175 CFU/nL, 1150 CFU/nL, and 375 CFU/nL). Graph shows a representative experiment of three independent infections (*n* = 40 larvae per group). The dilution of the bacteria induced a significant decrease of mortality (\**P* \< 0.05). **(B)** Bacterial burden of infected larvae at 0 and 24 hpi. A representative result (mean ± SEM) of two independent experiments is presented (*n* = 40 larvae per group). **(C)** Increased TNFα and IL1-β expression in infected larvae at 6 hpi (*n* = 30 larvae per group). **(D)** *In vivo* response of neutrophils after infection. *Tg(mpx:GFP+/+)* larvae were injected with *A. hydrophila* (200 CFU/nL) and imaged at 2, 4, and 24 hpi. **(E)** Total neutrophil counts in infected and control larvae in all the body (systemic infection) and in duct of Cuvier (local infection). Results represent the mean ± SEM of two independent experiments (*n* = 10 larvae per group; ANOVA and Tukey HSD test; \**P* \< 0.05, \*\**P* \< 0.01; \*\*\**P* \< 0.005).](fmicb-07-01219-g003){#F3}

The suitability of this infection model to the study of the immune response was analyzed by determining the expression of proinflammatory genes and by characterizing the response of neutrophils. Six hours after the injection of *A. hydrophila*, the expression of the TNFα gene in infected larvae was up to 20 times higher than the control larvae. The expression of the IL-1β gene was also increased but was only five times that of the control group (**Figure [3C](#F3){ref-type="fig"}**). The injection of *Tg(mpx:GFP+/+)* larvae revealed a fast recruitment of neutrophils around the injection site short time after infection (2 and 4 hpi; **Figure [3D](#F3){ref-type="fig"}**). A significant increase of total neutrophils was registered in all the body (systemic response) and in the injection site (local response) in all infected animals compared to the control groups, regardless of the sampling point. Moreover, a significant increase in the number of neutrophils was observed in infected animals from 2 to 24 hpi also in all the body and in the injection site (**Figure [3E](#F3){ref-type="fig"}**).

Development of the Bath Infection Model
---------------------------------------

Larvae at 4 dpf were used in this model because at this developmental stage the mouth is open and the bacteria suspended in the water can enter there. The injury to the tail fin provided an alternative portal of entry (**Figure [4A](#F4){ref-type="fig"}**). The experimental infection of larvae with *A. hydrophila* induced mortalities in both healthy and injured larvae (**Figure [4B](#F4){ref-type="fig"}**). In healthy larvae, mortalities began at 12 hpi and increased during the experiment, reaching a maximum cumulative mortality of 33% (±12) at 96 hpi and staying constant until the end of the experiment (**Figure [4B](#F4){ref-type="fig"}**). However, the same bacterial dose inoculated in injured larvae induced a significant increase of mortality (**Figure [4B](#F4){ref-type="fig"}**). In injured larvae, mortalities began soon after the infection. At 12 hpi cumulative mortalities reached 63% (±3) and increased up to 77% (±9) by the end of the experiment (**Figure [4B](#F4){ref-type="fig"}**). A 1% cumulative mortality was registered in injured larvae treated with PBS (control group) at the end of the experiment.

![**Development of bath infection model. (A)** Larvae were injured in the tail fin tip using a sapphire blade. **(B)** Cumulative mortality of healthy and injured larvae infected with *A. hydrophila* (10^8^ CFU/mL). Fish in the control group were injured in the tail fin and treated with PBS. Graph is a representative result of five independent experiments using 40 larvae in each experiment. The injury induced a significant increase of mortality (\**P* \< 0.05). **(C)** Bacterial burden in infected healthy and injured larvae at 1, 6, and 24 hpi. Data represent the mean ± SEM of two independent experiments (*n* = 40 larvae/each). Significant differences at \*\**P* \< 0.01.](fmicb-07-01219-g004){#F4}

To analyze the progression of the infection, the bacterial burden was calculated in the whole larvae at different times post-infection (**Figure [4C](#F4){ref-type="fig"}**). In healthy larvae, the number of bacteria inside the animal increased significantly from 6 to 24 hpi. The bacterial load per larva changed from 2.000 CFU at 6 hpi to 110.000 CFU at 24 h (55-fold; **Figure [4C](#F4){ref-type="fig"}**). In injured larvae, the bacterial burden was calculated at earlier time points than those used in healthy larvae (1 and 6 hpi) because mortalities occurred faster in this model. In these animals, the bacterial burden increased significantly from 400 CFU at 1 hpi to 2600 CFU at 6 hpi (6,5-fold; **Figure [4C](#F4){ref-type="fig"}**).

The *Tg(mpx:GFP+/+)* larvae were infected with the fluorescent *A. hydrophila* DsRed to localize the bacteria in infected larvae and to analyze the interaction of the bacteria with the neutrophils in the site of injury. Infected animals showed a higher number of neutrophils in this area compared to the animals that were injured but not infected (**Figure [5A](#F5){ref-type="fig"}**). Moreover, fluorescent bacteria were present in the skin surrounding the tail fin wound (**Figure [5A](#F5){ref-type="fig"}**). 3D reconstructions of multiple z-stack images of the wounded sites of infected larvae showed bacteria inside of the neutrophils (**Figure [5A](#F5){ref-type="fig"}**). When we quantified the increase in neutrophils in the wounds of injured larvae, infected animals showed a significantly higher recruitment of neutrophils in these areas compared to the injured but uninfected animals. The number of neutrophils in the wounds of infected larvae was fairly constant until 3 hpi. Uninfected larvae presented lower neutrophil recruitment, although it increased from 1 to 3 hpi (**Figure [5B](#F5){ref-type="fig"}**).

![**(A)** *In vivo* imaging of neutrophils from *Tg(mpx:GFP+/+)* larvae after injury and bath infection with *A. hydrophila* (10^8^ CFU/mL). Recruitment of neutrophils to the site of the injury 1 h after the bacterial infection. Control animals were injured but not infected. 3D reconstruction of a selected site in the infected sample showing the positions of the bacteria (red) inside the neutrophils (green). **(B)** Relative quantification of neutrophils in the site of injury. Results are representative of three independent experiments (*n* = 10--15 larvae each; ANOVA; \**P* \< 0.05, \*\**P* \< 0.01). **(C)** Expression of IL-1β and TNFα in injured larvae infected by bath immersion (10^8^ CFU/mL) at 1, 3, and 5 hpi. Results of three independent experimental infections (*n* = 30) expressed as the mean ± standard error (ANOVA and Tukey HSD test; \**P* \< 0.05, \*\**P* \< 0.01).](fmicb-07-01219-g005){#F5}

The immune response triggered by the infection in injured larvae was also assayed by measuring the expression of the proinflammatory genes IL-1β and TNFα (**Figure [5C](#F5){ref-type="fig"}**). The infection induced a very high expression of IL-1β as soon as 1 hpi, and it significantly increased over time, reaching up to 66 times the expression detected in control animals at 5 hpi. The TNFα gene showed a similar expression pattern, although the fold change was lower, reaching a value of 8.3 at 5 hpi (**Figure [5C](#F5){ref-type="fig"}**).

Discussion
==========

In this work an infection model using different routes for infection was established in zebrafish larvae to study the pathogenesis of *A. hydrophila* and the immune response triggered in the larvae. Two infection models were proposed: an early-embryo infection model at 3 dpf through microinjection into the duct of Cuvier, caudal vein, notochord, or muscle, and two bath infection models using 4 dpf healthy and injured larvae, to simulate the natural conditions by which *A. hydrophila* produces infectious diseases.

Microinjection allows the administration of a tightly controlled bacterial load into specific anatomical sites of the larvae ([@B8]; [@B52]). One of the most important parameters to control in this model is the bacterial dose. In our work, the injection of 3200 CFU/nL produced high mortality rates, making difficult the detection of differences between the injection sites. This observation has also been described by [@B52], who established the infection model of *Staphylococcus aureus* and reported differences in mortalities between the injection sites only at low bacterial dose.

Different sites of infection induce different effects. Local bacterial infections were produced after an injection in the muscle or notochord, whereas an injection in the duct of Cuvier or in the caudal vein induced a systemic infection. The distinction between local and systemic infection was also evidenced by the migration of neutrophils observed in infected *Tg(mpx:GFP+/+)*. Neutrophils migrate to the infection sites to phagocytose pathogens, to release antibacterial molecules from their granules and to regulate the inflammatory response by producing cytokines and other inflammation mediators ([@B60]; [@B46]). Regarding leukocyte migration, the injection in the muscle or notochord of *A. hydrophila* induced strong recruitment of neutrophils in the larvae, similar to other studies in mice injected intramuscularly with *A. hydrophila* ([@B45]) and in zebrafish infected with other bacterial pathogens ([@B52]; [@B25]; [@B70]). Interestingly, the injection of *A. hydrophila* in the caudal vein or in the duct of Cuvier induced a general increase in the number of total neutrophils. This increase in the number of neutrophils after a systemic challenge has been described using other bacterial models, such as *Shigella flexneri* and *Staphylococcus aureus* ([@B81]; [@B67]).

The infection of the transgenic zebrafish line *Tg(Il-1b:GFP-F+/+)* allowed the visualization of Il-1β gene expression in different organs. IL-1β is a marker for inflammation because it is produced after a bacterial infection to stimulate the extravasation of leukocytes to the infected sites and to activate the production of antimicrobial effectors ([@B26]). In our work, differential anatomical distribution of the IL-1β expression was observed between local and systemic infection. The local infection caused by injection of bacteria in the muscle or notochord induced the expression of IL-1β mainly around the site of infection. This gene expression pattern has been described in local injection of zebrafish larvae with *E. coli* ([@B70]). The systemic infection of *A. hydrophila* induced an unexpectedly high expression of IL-1β mainly along the intestine. Moreover, increased IL-1β expression was observed in both local and systemic infections in other tissues, such as the gills and the tail fin. The expression of IL-1β in the embryo tail fin was not related to the experimental infection because GFP is constitutively expressed in *Tg(Il-1b:GFP-F+/+)* embryos after 50 h post fertilization in keratinocytes at the tip of the caudal fin and in fin buds, retina, neuromasts, gills, and thymus ([@B70]). Further studies are needed to clarify the role of IL-1β in the intestine and gills in response to *A. hydrophila* infection.

In the zebrafish embryo, the duct of Cuvier is considered one of the best routes for pathogen administration. It connects the cardinal veins to the sinus venosus of the heart ([@B41]), thus allowing the injection into circulation of a definite quantity of pathogen ([@B21]; [@B8]; [@B101]). By injecting through the duct of Cuvier, we generated a controlled systemic infection that was able to produce robust and reproducible mortalities in a dose-dependent manner. The injection of bacteria in the blood produced an infection without significant changes in bacterial burden. This is not surprising: although the blood is a good medium for bacteria to proliferate ([@B52]), the ability of larvae to control the proliferation of *A. hydrophila* was probably related to the low dose used for the injections, as demonstrated previously for other bacterial species ([@B67]).

The inflammatory process started soon after the injection. The TNFα gene is also a key molecule of inflammatory process contributing to the activation of leukocytes and their recruitment to the infection site ([@B105]; [@B11]). In our work, high increases of TNFα and IL-1β gene expression were registered after *A. hydrophila* challenge, in accordance with previous studies in mice and adult fish ([@B31]; [@B86]). Variations in the expression of inflammatory genes were accompanied by a quick increase of total neutrophils. In the first hours post-challenge, the injection in the duct of Cuvier induced a local migration to the injection site, but at 24 hpi, a generalized increase in total neutrophils was observed. This result suggests that this infection model is suitable for studying both the early local response and the late systemic one. Methodologically, the use of the transgenic zebrafish larvae *Tg(mpx:GFP+/+)* in combination with fluorescent microscopy presents clear advantages compared to the classical quantification of leukocytes by flow cytometry in mice and adult fish ([@B86]; [@B93]; [@B43]).

*Aeromonas hydrophila* is a water-borne bacterium that can infect humans through the mouth and wounds in the skin ([@B42]; [@B7]). For this reason, a bath infection model resembling the natural conditions of infection was developed. Larvae at 4 dpf were used to ensure the mouth was open, and in one group, we also inflicted a small injury in the tail fin tip to promote a wound infection. Injured larvae showed a significantly faster and higher mortality rate than healthy larvae when challenged with the same concentration of *A. hydrophila*. Similar observations have been described in experimental infections with *A. hydrophila* using adult zebrafish ([@B86]), thus suggesting the opportunistic nature of this bacterium ([@B42]). The generation of an alternative portal of entry to the bacteria allows the development of a faster infectious process and the use of a lower bacterial dose to induce mortality levels similar to those induced in infected healthy larvae. We must note that the result could have been different if the bath infection had been performed at different times post-injury, but this should be further explored. The higher bacterial concentration required in this model compared to the microinjection model highlights the harmfulness of this bacterium when it is inside the blood circulation or tissues of animals. The increase of the bacterial burden after bath infection suggests that *A. hydrophila* was able to produce a stable infection in this model. Moreover, the higher bacterial burden recovered from injured larvae at 6 hpi indicates that wounds favored *A. hydrophila* adherence and colonization in the host and thus the disease.

Confocal microscopy analysis of *Tg(mpx:GFP+/+)* larvae infected with the fluorescent *A. hydrophila*-DsRed revealed the presence of adhered bacteria only in the wounded sites, indicating that surface injuries promoted the bacterial attachment to the skin ([@B6]; [@B65]; [@B9]). Several studies in zebrafish have demonstrated the migration of neutrophils to the injured sites to contribute to the inflammation process and healing ([@B109]; [@B24]). Interestingly, a significant increase in neutrophil recruitment to the fin wound was observed after infection, suggesting that *A. hydrophila* amplified the inflammatory response to the tail. 3D reconstruction analysis revealed that zebrafish neutrophils can also phagocytose *A. hydrophila* associated to the body surface, in line with previous observations ([@B22]).

Tissue injuries induce an inflammatory status with the expression of IL1-β, TNFα and other proinflammatory genes ([@B30]). We found higher expression levels of IL1-β and TNFα at different times post-infection in injured larvae compared to injured but uninfected larvae. This result suggests that *A. hydrophila* can amplify the inflammatory response induced by the tail fin injury. Thus, the increased expression of IL1-β triggered by *A. hydrophila* could have enhanced the recruitment of neutrophils to the wounds in infected larvae because IL1-β regulates the recruitment of leukocytes to the injury sites ([@B73]; [@B108]). All of these results show that skin injuries promote the bacterial attachment to larvae, which in turn induces a significant increase of the neutrophil recruitment to the wound and primes a very strong inflammatory response.

Conclusion
==========

Two infection models were established in zebrafish larvae to study *A. hydrophila* pathogenesis. Microinjection in the duct of Cuvier allows the generation of a controlled systemic infection, and bath infection in injured larvae mimics the natural routes of infection. Both models presented here will be useful for the study different aspects of *A. hydrophila* infection.
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